Literature DB >> 20109515

Synthesis and evaluation of conformationally constrained peptide analogues as the Src SH3 domain binding ligands.

Rakesh Tiwari1, Alex Brown, Seetha Narramaneni, Gongqin Sun, Keykavous Parang.   

Abstract

Src kinase activity is regulated by the interaction of SH3 domain with protein sequences that are rich in proline residues. Identification of more potent SH3 domain binding ligands that can regulate Src kinase activity is a subject of major interest. Conformationally constrained peptides have been previously used for improving the binding potency of the Src SH2 domain binding peptide ligands and peptide substrates of the substrate-binding site of Src. A series of peptide analogues of Ac-VSLARRPLPPLP (1, Ac-VSL12, Kd=0.34 microM) were synthesized by introducing conformational constraints to improve the binding affinity towards the Src SH3 domain. Peptides synthesized through cyclization between N-terminal to C-terminal [VSLARRPLPPLP] or N-terminal to side chain flanking residues (i.e., [(beta)AVS]LARRPLPPLP and [VSLE]RRPLPPLP) exhibited at least 6.4-fold less binding affinity (Kd=2.19-4.85 microM) when compared to 1. The data suggest upon N-terminal cyclization with C-terminal or flanking residues, the interactions of the amino acids in the core RPLPPLP reduce significantly with the residues within the Src SH3 domain. Conformationally constrained peptide V[SLARRPLPPLP] (5) was synthesized through cyclization of C-terminal to the serine side chain and displayed a comparable binding affinity (Kd=0.35 microM) towards the Src SH3 domain versus that of 1. Thus, this template may be used to optimize and generate more potent analogues with higher stability. Copyright (c) 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20109515     DOI: 10.1016/j.biochi.2010.01.017

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  5 in total

Review 1.  Targeting kinase signaling pathways with constrained peptide scaffolds.

Authors:  Laura E Hanold; Melody D Fulton; Eileen J Kennedy
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

2.  Design, Synthesis, and Evaluation of Dasatinib-Amino Acid and Dasatinib-Fatty Acid Conjugates as Protein Tyrosine Kinase Inhibitors.

Authors:  Rakesh K Tiwari; Alex Brown; Neda Sadeghiani; Amir Nasrolahi Shirazi; Jared Bolton; Amanda Tse; Gennady Verkhivker; Keykavous Parang; Gongqin Sun
Journal:  ChemMedChem       Date:  2016-12-05       Impact factor: 3.466

3.  Cyclic Peptides as Protein Kinase Inhibitors: Structure-Activity Relationship and Molecular Modeling.

Authors:  Michel F Sanner; Khalid Zoghebi; Samara Hanna; Saghar Mozaffari; Simin Rahighi; Rakesh K Tiwari; Keykavous Parang
Journal:  J Chem Inf Model       Date:  2021-05-17       Impact factor: 6.162

4.  4-Aryl-4H-naphthopyrans derivatives: one-pot synthesis, evaluation of Src kinase inhibitory and anti-proliferative activities.

Authors:  Ali Rafinejad; Asal Fallah-Tafti; Rakesh Tiwari; Amir Nasrolahi Shirazi; Deendayal Mandal; Abbas Shafiee; Keykavous Parang; Alireza Foroumadi; Tahmineh Akbarzadeh
Journal:  Daru       Date:  2012-12-26       Impact factor: 3.117

5.  A PDK-1 allosteric agonist neutralizes insulin signaling derangements and beta-amyloid toxicity in neuronal cells and in vitro.

Authors:  Henry Querfurth; John Marshall; Keykavous Parang; Mengia S Rioult-Pedotti; Rakesh Tiwari; Bumsup Kwon; Steve Reisinger; Han-Kyu Lee
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.